Myocardial Perfusion Abnormalities in Patients with Active Acromegaly

Abstract

Cardiomyopathy is often seen in patients with a long history of acromegaly. In order to screen for perfusion abnormalities, patients with active acromegaly without evidence for coronary heart disease were examined by single photon emission computed tomography (SPECT). The study included a group of 11 strictly selected patients with active acromegaly (7 males and 4 females; age 51 ± 12 y [mean ± S.D.]) with elevated age-adjusted IGF-I levels (IGF-I 569 ± 193 µg/l; GH 31.2 ± 56.3 µg/l) compared to an age- and sex-matched non-acromegalic control group with comparable muscle mass index of the left ventricle (126 ± 41 active vs. 122 ± 33 g/m² control group) and body mass index (26.6 ± 2.7 vs. 27.0 ± 5.0 kg/m²). To address this issue, myocardial perfusion was investigated by single photon emission computed tomography (SPECT) using a triple head gamma-camera. 70 MBq ²⁰¹TlCl was injected, and post-stress (from bicycle ergometer) images were obtained. Images were interpreted quantitatively by bull's eye polary map (16 regions of the left ventricle) and were compared to the control group. In the patients with active acromegaly, the mean nuclide uptake of the 16 regions of the left ventricle after bicycle stress examination was lower than in the control group (82.99 ± 2.85 active vs 85.48 ± 1.29 control group, p < 0.01). Non-homogeneity of nuclide uptake was defined as the standard deviations of the 16 regions and was higher in patients with active acromegaly (11.11 ± 2.35 active vs. 8.77 ± 1.39 control group, p < 0.01). In conclusion, myocardial perfusion is impaired in patients with active acromegaly, thus representing an early stage of cardiac involvement in acromegaly that may be directly mediated by growth hormone excess.

Acromegaly - Impaired Myocardial Perfusion - Scintigraphy

References

• 1 Drange M R, Fram N R, Herman-Bonert V, Melmed S. Pituitary tumor registry: a novel clinical resource.  J Clin Endocrinol Metab. 2000;  85 168-174
• 2 Lombardi G, Colao A, Cuocolo A, Longobardi S, di Somma C, Orio F, Merola B, Nicolai E, Salvatore M. Cardiological aspects of growth hormone and insulin-like growth factor- I.  J Pediatr Endocrinol Metab. 1997;  10 553-560
• 3 Lombardi G, Colao A, Ferone D, Marzullo P, Orio F, Longobardi S, Merola B. Effect of growth hormone on cardiac function.  Horm Res. 1997;  48 38-42
• 4 Kahaly G, Olshausen K V, Mohr-Kahaly S, Erbel R, Boor S, Beyer J, Meyer J. Arrhythmia profile in acromegaly.  Eur Heart J. 1992;  13 51-56
• 5 Kahaly G, Stover C, Beyer J, Mohr-Kahaly S. Relation of endocrine and cardiac findings in acromegalics.  J Endocrinol Invest. 1992;  15 13-18
• 6 Ozbey N, Oncul A, Bugra Z, Vural A, Erzengin F, Orhan Y, Buyukozturk K, Sencer E, Molvalilar S. Acromegalic cardiomyopathy: evaluation of the left ventricular diastolic function in the subclinical stage.  J Endocrinol Invest. 1997;  20 305-311
• 7 Herrmann B L, Bruch C, Saller B, Ferdin S, Dagres N, Ose C, Erbel R, Mann K. Occurrence of ventricular late potentials in patients with active acromegaly.  Clin Endocrinol (Oxf). 2001;  55 201-207
• 8 Herrmann B L, Bruch C, Saller B, Bartel T, Ferdin S, Erbel R, Mann K. Acromegaly: evidence for a direct relation between disease activity and cardiac dysfunction in patients without ventricular hypertrophy.  Clin Endocrinol (Oxf). 2002;  56 595-602
• 9 Galanti G, Cappelli B, Diricatti G, Mininni S, Vono M C, Gensini G F. Systolic and diastolic cardiac function in acromegaly. An echocardiographic study.  Ann Ital Med Int. 1996;  11 27-32
• 10 Cuocolo A, Nicolai E, Fazio S, Pace L, Maurea S, Cittadini A, Sacca L, Salvatore M. Impaired left ventricular diastolic filling in patients with acromegaly: assessment with radionuclide angiography.  J Nucl Med. 1995;  36 196-201
• 11 Sacca L, Cittadini A, Fazio S. Growth hormone and the heart.  Endocr Rev. 1994;  15 555-573
• 12 Lopez-Velasco R, Escobar-Morreale H F, Vega B, Villa E, Sancho J M, Moya-Mur J L, Garcia-Robles R. Cardiac involvement in acromegaly: specific myocardiopathy or consequence of systemic hypertension?.  J Clin Endocrinol Metab. 1997;  82 1047-1053
• 13 Minniti G, Jaffrain-Rea M L, Moroni C, Baldelli R, Ferretti E, Cassone R, Gulino A, Tamburrano G. Echocardiographic evidence for a direct effect of GH/IGF-I hypersecretion on cardiac mass and function in young acromegalics.  Clin Endocrinol (Oxf). 1998;  49 101-106
• 14 D'Angio C T, Ambati J, Phelps D L. Do urinary levels of vascular endothelial growth factor predict proliferative retinopathy?.  Curr Eye Res. 2001;  22 90-94
• 15 Kwak N, Okamoto N, Wood J M, Campochiaro P A. VEGF is major stimulator in model of choroidal neovascularization.  Invest Ophthalmol Vis Sci. 2000;  41 3158-3164
• 16 Lip P L, Belgore F, Blann A D, Hope-Ross M W, Gibson J M, Lip G Y. Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: relationship to endothelial dysfunction and laser treatment.  Invest Ophthalmol Vis Sci. 2000;  41 2115-2119
• 17 Aiello L P, Avery R L, Arrigg P G, Keyt B A, Jampel H D, Shah S T, Pasquale L R, Thieme H, Iwamoto M A, Park J E. et al . Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.  N Engl J Med. 1994;  331 1480-1487
• 18 Wells J A, Murthy R, Chibber R, Nunn A, Molinatti P A, Kohner E M, Gregor Z J. Levels of vascular endothelial growth factor are elevated in the vitreous of patients with subretinal neovascularisation.  Br J Ophthalmol. 1996;  80 363-366
• 19 Nagai Y, Ando H, Nohara E, Yamashita H, Takamura T, Kobayashi K. Plasma levels of vascular endothelial growth factor in patients with acromegaly.  Horm Metab Res. 2000;  32 326-329
• 20 Evans L M, Davies J S. Heterogeneous haemodynamics in acromegaly: evidence of endothelial dysfunction?.  Clin Endocrinol (Oxf). 1998;  49 711-712
• 21 Chanson P, Megnien J L, del Pino M, Coirault C, Merli I, Houdouin L, Harris A G, Levenson J, Lecarpentier Y, Simon A, Chemla D. Decreased regional blood flow in patients with acromegaly.  Clin Endocrinol (Oxf). 1998;  49 725-731
• 22 Wieneke H, Zander C, Eising E G, Haude M, Bockisch A, Erbel R. Non-invasive characterization of cardiac microvascular disease by nuclear medicine using single-photon emission tomography.  Herz. 1999;  24 515-521
• 23 Astarita C, Nicolai E, Liguori E, Gambardella S, Rumolo S, Maresca F S. Dipyridamole-echocardiography and thallium exercise myocardial scintigraphy in the diagnosis of obstructive coronary or microvascular disease in hypertensive patients with left ventricular hypertrophy and angina.  G Ital Cardiol. 1998;  28 996-1004
• 24 Giustina A, Barkan A, Casanueva F F, Cavagnini F, Frohman L, Ho K, Veldhuis J, Wass J, von Werder K, Melmed S. Criteria for cure of acromegaly: a consensus statement.  J Clin Endocrinol Metab. 2000;  85 526-529
• 25 Buell U, Stirner H, von Dahl J, Uebis R, Kleinhans E, Biedermann M, Grosse W, Simon H J. Quantitative evaluation of myocardial stress/rest 201TL SPECT: results of a ROI-based method in 108 patients with CHD.  Nuklearmedizin. 1987;  26 234-240
• 26 Radziuk J. Insulin sensitivity and its measurement: structural commonalities among the methods.  J Clin Endocrinol Metab. 2000;  85 4426-4433
• 27 Matthews D R, Hosker J P, Rudenski A S, Naylor B A, Treacher D F, Turner R C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.  Diabetologia. 1985;  28 412-419
• 28 Haffner S M, Miettinen H, Stern M P. The homeostasis model in the San Antonio Heart Study.  Diabetes Care. 1997;  20 1087-1092
• 29 Colao A, Baldelli R, Marzullo P, Ferretti E, Ferone D, Gargiulo P, Petretta M, Tamburrano G, Lombardi G, Liuzzi A. Systemic hypertension and impaired glucose tolerance are independently correlated to the severity of the acromegalic cardiomyopathy.  J Clin Endocrinol Metab. 2000;  85 193-199
• 30 Moller N, Jorgensen J O, Abildgard N, Orskov L, Schmitz O, Christiansen J S. Effects of growth hormone on glucose metabolism.  Horm Res. 1991;  36 32-35
• 31 Oscarsson J, Wiklund O, Jakobsson K E, Petruson B, Bengtsson B A. Serum lipoproteins in acromegaly before and 6 - 15 months after transsphenoidal adenomectomy.  Clin Endocrinol (Oxf). 1994;  41 603-608
• 32 Tsuchiya H, Onishi T, Mogami H, Iida M. Lipid metabolism in acromegalic patients before and after selective pituitary adenomectomy.  Endocrinol Jpn. 1990;  37 797-807
• 33 Colao A, Cuocolo A, Marzullo P, Nicolai E, Ferone D, Florimonte L, Salvatore M, Lombardi G. Effects of 1-year treatment with octreotide on cardiac performance in patients with acromegaly.  J Clin Endocrinol Metab. 1999;  84 17-23
• 34 Colao A, Marzullo P, Ferone D, Marino V, Pivonello R, di Somma C, di Sarno A, Giaccio A, Lombardi G. Effectiveness and tolerability of slow release lanreotide treatment in active acromegaly.  J Endocrinol Invest. 1999;  22 40-47
• 35 Fazio S, Cittadini A, Cuocolo A, Merola B, Sabatini D, Colao A, Biondi B, Lombardi G, Sacca L. Impaired cardiac performance is a distinct feature of uncomplicated acromegaly.  J Clin Endocrinol Metab. 1994;  79 441-446
• 36 Fazio S, Cittadini A, Sabatini D, Merola B, Colao A M, Biondi B, Lombardi G, Sacca L. Evidence for biventricular involvement in acromegaly: a Doppler echocardiographic study.  Eur Heart J. 1993;  14 26-33
• 37 Takata J, Counihan P J, Gane J N, Doi Y, Chikamori T, Ozawa T, McKenna W J. Regional thallium-201 washout and myocardial hypertrophy in hypertrophic cardiomyopathy and its relation to exertional chest pain.  Am J Cardiol. 1993;  72 211-217
• 38 Wackers F J. Myocardial perfusion imaging in ischemic heart disease anno 1990.  Curr Opin Cardiol. 1991;  6 590-601
• 39 Wackers F J. The birth of a new radiopharmaceutical. Clinical investigative perspective.  J Nucl Cardiol. 1995;  2 75-77
• 40 Hutchins P M, Lynch C D, Cooney P T, Curseen K A. The microcirculation in experimental hypertension and aging.  Cardiovasc Res. 1996;  32 772-780
• 41 Lie J T. Pathology of the heart in acromegaly: anatomic findings in 27 autopsied patients.  Am Heart J. 1980;  100 41-52
• 42 Frustaci A, Chimenti C, Setoguchi M, Guerra S, Corsello S, Crea F, Leri A, Kajstura J, Anversa P, Maseri A. Cell death in acromegalic cardiomyopathy.  Circulation. 1999;  99 1426-1434
• 43 Feinstein S B, Voci P, Pizzuto F. Noninvasive surrogate markers of atherosclerosis.  Am J Cardiol. 2002;  89 31C-43C; discussion 43C-44C
• 44 Yamashita N, Nakayama Y, Tsumura K, Nishijima T, Ueda H, Yoshimaru K, Hayashi T, Yoshikawa J. Pulsatility of brachial artery pressure is associated with an increased risk of coronary artery disease in men.  J Hypertens. 2001;  19 1589-1593
• 45 Anderson T J, Uehata A, Gerhard M D, Meredith I T, Knab S, Delagrange D, Lieberman E H, Ganz P, Creager M A, Yeung A C. et al . Close relation of endothelial function in the human coronary and peripheral circulations.  J Am Coll Cardiol. 1995;  26 1235-1241
• 46 Enderle M D, Schroeder S, Ossen R, Meisner C, Baumbach A, Haering H U, Karsch K R, Pfohl M. Comparison of peripheral endothelial dysfunction and intimal media thickness in patients with suspected coronary artery disease.  Heart. 1998;  80 349-354
• 47 Heusch G. Hibernating myocardium.  Physiol Rev. 1998;  78 1055-1085
• 48 Hasdai D, Nielsen M F, Rizza R A, Holmes D R, Richardson D M, Cohen P, Lerman A. Attenuated in vitro coronary arteriolar vasorelaxation to insulin-like growth factor I in experimental hypercholesterolemia.  Hypertension. 1999;  34 89-95
• 49 Hansen I, Tsalikian E, Beaufrere B, Gerich J, Haymond M, Rizza R. Insulin resistance in acromegaly: defects in both hepatic and extrahepatic insulin action.  Am J Physiol. 1986;  250 E269-E273
• 50 Rizza R A, Mandarino L J, Gerich J E. Effects of growth hormone on insulin action in man. Mechanisms of insulin resistance, impaired suppression of glucose production, and impaired stimulation of glucose utilization.  Diabetes. 1982;  31 663-669
• 51 Lepej J, Spisiakova D, Hrnciar J, Okapcova J, Szentivanyi M, Kurray P. Thallium scintigraphy of the myocardium in evaluation of patients with insulin resistance syndrome and microvascular angina pectoris.  Vnitr Lek. 2000;  46 205-212
• 52 Pinkney J H, Stehouwer C D, Coppack S W, Yudkin J S. Endothelial dysfunction: cause of the insulin resistance syndrome.  Diabetes. 1997;  46 S9-S13